ATE218209T1 - In vitro multizellular test von angiogenesis - Google Patents
In vitro multizellular test von angiogenesisInfo
- Publication number
- ATE218209T1 ATE218209T1 AT98944120T AT98944120T ATE218209T1 AT E218209 T1 ATE218209 T1 AT E218209T1 AT 98944120 T AT98944120 T AT 98944120T AT 98944120 T AT98944120 T AT 98944120T AT E218209 T1 ATE218209 T1 AT E218209T1
- Authority
- AT
- Austria
- Prior art keywords
- angiogenesis
- vitro
- cellular test
- vitro multi
- combined
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9720987.8A GB9720987D0 (en) | 1997-10-01 | 1997-10-01 | A multicellular in vitro assay of angiogenesis |
| PCT/GB1998/002908 WO1999017116A1 (en) | 1997-10-01 | 1998-09-25 | A multicellular in vitro assay of angiogenesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218209T1 true ATE218209T1 (de) | 2002-06-15 |
Family
ID=10819980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98944120T ATE218209T1 (de) | 1997-10-01 | 1998-09-25 | In vitro multizellular test von angiogenesis |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1023599B1 (de) |
| JP (1) | JP3404572B2 (de) |
| AT (1) | ATE218209T1 (de) |
| AU (1) | AU732538B2 (de) |
| CA (1) | CA2301171C (de) |
| DE (1) | DE69805644T2 (de) |
| DK (1) | DK1023599T3 (de) |
| ES (1) | ES2174486T3 (de) |
| GB (1) | GB9720987D0 (de) |
| IL (1) | IL135386A0 (de) |
| MY (1) | MY119061A (de) |
| NO (1) | NO20001608L (de) |
| NZ (1) | NZ502962A (de) |
| WO (1) | WO1999017116A1 (de) |
| ZA (1) | ZA988936B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6651008B1 (en) | 1999-05-14 | 2003-11-18 | Cytokinetics, Inc. | Database system including computer code for predictive cellular bioinformatics |
| US6743576B1 (en) | 1999-05-14 | 2004-06-01 | Cytokinetics, Inc. | Database system for predictive cellular bioinformatics |
| US7151847B2 (en) | 2001-02-20 | 2006-12-19 | Cytokinetics, Inc. | Image analysis of the golgi complex |
| US6436629B1 (en) * | 2000-10-27 | 2002-08-20 | The Regents Of The University Of California | Modulating angiogenesis |
| US7218764B2 (en) | 2000-12-04 | 2007-05-15 | Cytokinetics, Inc. | Ploidy classification method |
| US6599694B2 (en) | 2000-12-18 | 2003-07-29 | Cytokinetics, Inc. | Method of characterizing potential therapeutics by determining cell-cell interactions |
| US7016787B2 (en) | 2001-02-20 | 2006-03-21 | Cytokinetics, Inc. | Characterizing biological stimuli by response curves |
| US6956961B2 (en) | 2001-02-20 | 2005-10-18 | Cytokinetics, Inc. | Extracting shape information contained in cell images |
| ES2185493B1 (es) * | 2001-07-03 | 2004-06-16 | Madrid Genetics, S.L. | Metodo para evaluar in vitro en condiciones fisiologicas o patologicas relevantes la actividad biologica de compuestos a gran escala. |
| US20050014217A1 (en) | 2003-07-18 | 2005-01-20 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
| US7235353B2 (en) | 2003-07-18 | 2007-06-26 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
| EP1646926A2 (de) | 2003-07-18 | 2006-04-19 | Cytokinetics, Inc. | Charakterisierung biologischer stimuli durch ansprechkurven |
| US7323318B2 (en) | 2004-07-15 | 2008-01-29 | Cytokinetics, Inc. | Assay for distinguishing live and dead cells |
| US8679836B2 (en) | 2007-10-01 | 2014-03-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4539716A (en) * | 1981-03-19 | 1985-09-10 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
| US4546500A (en) * | 1981-05-08 | 1985-10-15 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
| US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
| US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
| US5830708A (en) * | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
-
1997
- 1997-10-01 GB GBGB9720987.8A patent/GB9720987D0/en not_active Ceased
-
1998
- 1998-09-25 NZ NZ502962A patent/NZ502962A/en unknown
- 1998-09-25 AU AU91785/98A patent/AU732538B2/en not_active Ceased
- 1998-09-25 WO PCT/GB1998/002908 patent/WO1999017116A1/en active IP Right Grant
- 1998-09-25 EP EP98944120A patent/EP1023599B1/de not_active Expired - Lifetime
- 1998-09-25 DK DK98944120T patent/DK1023599T3/da active
- 1998-09-25 AT AT98944120T patent/ATE218209T1/de not_active IP Right Cessation
- 1998-09-25 JP JP2000514134A patent/JP3404572B2/ja not_active Expired - Fee Related
- 1998-09-25 DE DE69805644T patent/DE69805644T2/de not_active Expired - Fee Related
- 1998-09-25 CA CA002301171A patent/CA2301171C/en not_active Expired - Fee Related
- 1998-09-25 IL IL13538698A patent/IL135386A0/xx unknown
- 1998-09-25 ES ES98944120T patent/ES2174486T3/es not_active Expired - Lifetime
- 1998-09-30 ZA ZA988936A patent/ZA988936B/xx unknown
- 1998-09-30 MY MYPI98004483A patent/MY119061A/en unknown
-
2000
- 2000-03-28 NO NO20001608A patent/NO20001608L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1023599A1 (de) | 2000-08-02 |
| CA2301171A1 (en) | 1999-04-08 |
| WO1999017116A1 (en) | 1999-04-08 |
| IL135386A0 (en) | 2001-05-20 |
| AU732538B2 (en) | 2001-04-26 |
| JP2001518621A (ja) | 2001-10-16 |
| ZA988936B (en) | 1999-03-31 |
| NZ502962A (en) | 2001-01-26 |
| DE69805644T2 (de) | 2002-09-12 |
| NO20001608D0 (no) | 2000-03-28 |
| MY119061A (en) | 2005-03-31 |
| EP1023599B1 (de) | 2002-05-29 |
| CA2301171C (en) | 2002-11-12 |
| AU9178598A (en) | 1999-04-23 |
| ES2174486T3 (es) | 2002-11-01 |
| JP3404572B2 (ja) | 2003-05-12 |
| DE69805644D1 (de) | 2002-07-04 |
| GB9720987D0 (en) | 1997-12-03 |
| NO20001608L (no) | 2000-03-28 |
| DK1023599T3 (da) | 2002-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE218209T1 (de) | In vitro multizellular test von angiogenesis | |
| AR018023A1 (es) | Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada | |
| ATE331025T2 (de) | Medium für die protein- und serumfreie zellkultur | |
| DE69725587D1 (de) | Verwendung von wnt polypeptiden | |
| DK1749543T3 (da) | Sammensætning til vævsregeneration | |
| DK1244808T3 (da) | Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner | |
| ATE297987T1 (de) | Bedingte immortalisierung von zellen | |
| DE69617583D1 (de) | In vitrozellkultur-System | |
| ATE226632T1 (de) | Serumfreies medium für säugetierzellen | |
| DE69631972D1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
| ATE304595T1 (de) | Lichtproduzierender biosensor | |
| TR200000140T2 (tr) | Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi | |
| FR2716205B1 (fr) | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. | |
| PT880594E (pt) | Vector retroviral e sua utilizacao em terapia genica | |
| DE69214116D1 (de) | In vitro Analyse von Molekülen an ihrer Produktionsstelle durch die Zellkultur | |
| DE69836336D1 (de) | Regulation der ausschleusung von proteinen | |
| IL97048A0 (en) | Bioluminescence assay for gene expression in growing mammalian cells | |
| DE69634363D1 (de) | Vorläufer von normalen neuralen epithelzellen | |
| DK0994955T3 (da) | Öget produktion af secernerede proteiner med rekombinante gærceller | |
| ATE97958T1 (de) | Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c. | |
| EA200701000A1 (ru) | Культуральная среда для клеток млекопитающих, не содержащая сыворотки | |
| NO20015181D0 (no) | Ekspresjon av heparin-bindende protein i rekombinante pattedyrceller | |
| JPS55113237A (en) | Gas discharge display panel | |
| ATE393819T1 (de) | Verwendungen von immortalisierten, homozygoten stat1-defizienten säugerzelllinien | |
| ATE403863T1 (de) | Verfahren zum nachweis von intrazellulären atp und/oder genexpression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |